Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its chiral structure makes it valuable in asymmetric synthesis, where stereochemistry plays a critical role in drug efficacy. Commonly employed in the preparation of protease inhibitors and receptor modulators due to the stability and protective nature of the tert-butoxycarbonyl (Boc) group. Enables selective reactions at nitrogen sites in multi-step organic syntheses, especially in peptide-like frameworks.